["{\n\"step_by_step_thinking\": \"The question is about a pregnant diabetic female who is shifted from oral hypoglycemics to insulin. Insulin requirement increases during pregnancy. Oral sulphonylureas like tolbutamide are known to cross the placenta and increase the risk of fetal hypoglycemia. Additionally, sulphonylureas can cause PIH (Pregnancy Induced Hypertension). Therefore, insulin is a better option for controlling blood sugar levels during pregnancy.\",\n\"answer_choice\": \"C\"\n}"]